Erratum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147))

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Willett, CG; Boucher, Y; Di Tomaso, E; Duda, DG; Munn, LL; Tong, RT; Chung, DC; Sahani, DV; Kalva, SP; Kozin, SV; Mino, M; Cohen, KS; Scadden, DT; Hartford, AC; Fischman, AJ; Clark, JW; Ryan, DP; Zhu, AX; Blaszkowsky, LS; Chen, HX; Shellito, PC; Lauwers, GY; Jain, RK

Published Date

  • January 1, 2004

Published In

Volume / Issue

  • 10 / 6

Start / End Page

  • 649 -

International Standard Serial Number (ISSN)

  • 1078-8956

Digital Object Identifier (DOI)

  • 10.1038/nm0604-649c

Citation Source

  • Scopus